Evaluation of multiple cellular, acellular, and matrix-like products (CAMPs) and standard of care vs. standard of care alone in the treatment of nonhealing diabetic foot ulcers

Abstract

Evaluation of multiple cellular, acellular, and matrix-like products (CAMPs) and standard of care versus standard of care alone in the treatment of nonhealing diabetic foot ulcers: an interim analysis of the CAMPFIRE clinical trial Thomas Serena1 MD | Brianna Tramelli1 | Stephanie Wilkins1 | Zwelithini Tunyiswa2 1 SerenaGroup, Inc., Cambridge, MA | 2Open Wound Research, Puyallup, WA

Keywords

Related in CAMP Studies and Therapeutics

• Cellular, acellular, and matrix-like products (CAMPs) for soft-tissue reconstruction in acute surgical and traumatic wounds
• Suggested minimal evidence for CAMP coverage
• Evaluation of human placental-based cellular, acellular and matrix-like products (CAMPs) in the management of nonhealing diabetic foot ulcers